Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 0.800 Q2 | 202 | 400 | 1146 | 53423 | 5306 | 1047 | 4.20 | 133.56 | |
2 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.403 Q3 | 108 | 206 | 647 | 13625 | 1619 | 632 | 2.26 | 66.14 | |
3 | Current Drug Targets | journal | 0.654 Q2 | 119 | 139 | 451 | 13590 | 1581 | 431 | 2.91 | 97.77 | |
4 | Letters in Drug Design and Discovery | journal | 0.213 Q4 | 37 | 96 | 421 | 4819 | 462 | 397 | 1.01 | 50.20 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.512 Q3 | 107 | 181 | 393 | 19853 | 1484 | 386 | 3.51 | 109.69 | |
6 | Letters in Organic Chemistry | journal | 0.181 Q4 | 33 | 112 | 406 | 4551 | 319 | 372 | 0.78 | 40.63 | |
7 | Current Protein and Peptide Science | journal | 0.602 Q3 | 96 | 72 | 343 | 7634 | 1110 | 312 | 2.90 | 106.03 | |
8 | Current Pharmaceutical Analysis | journal | 0.177 Q4 | 27 | 114 | 308 | 4818 | 196 | 303 | 0.59 | 42.26 | |
9 | Current Bioinformatics | journal | 0.461 Q3 | 38 | 122 | 271 | 6015 | 1089 | 256 | 4.71 | 49.30 | |
10 | Current Cancer Drug Targets | journal | 0.732 Q3 | 103 | 72 | 243 | 6575 | 863 | 231 | 2.78 | 91.32 | |
11 | Current Diabetes Reviews | journal | 0.505 Q3 | 68 | 102 | 237 | 7636 | 638 | 231 | 2.62 | 74.86 | |
12 | Current Organic Synthesis | journal | 0.330 Q4 | 55 | 58 | 233 | 3781 | 470 | 220 | 2.18 | 65.19 | |
13 | Current Nanoscience | journal | 0.310 Q3 | 52 | 76 | 225 | 6153 | 385 | 218 | 1.62 | 80.96 | |
14 | Infectious Disorders - Drug Targets | journal | 0.319 Q4 | 61 | 152 | 210 | 5134 | 317 | 200 | 1.30 | 33.78 | |
15 | Current Genomics | journal | 0.596 Q3 | 77 | 52 | 189 | 4495 | 542 | 163 | 2.56 | 86.44 | |
16 | Current Computer-Aided Drug Design | journal | 0.258 Q4 | 32 | 82 | 151 | 3213 | 217 | 142 | 1.53 | 39.18 | |
17 | Current Proteomics | journal | 0.155 Q4 | 27 | 65 | 134 | 3625 | 80 | 124 | 0.61 | 55.77 | |
18 | Current Gene Therapy | journal | 0.656 Q3 | 80 | 40 | 123 | 3569 | 493 | 107 | 4.28 | 89.23 | |
19 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.300 Q4 | 45 | 38 | 99 | 1417 | 149 | 94 | 1.09 | 37.29 | |
20 | Current Molecular Pharmacology | journal | 0.729 Q2 | 49 | 106 | 94 | 8305 | 359 | 90 | 3.87 | 78.35 | |
21 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.629 Q3 | 52 | 42 | 88 | 3536 | 322 | 85 | 2.84 | 84.19 | |
22 | Recent Patents on Biotechnology | journal | 0.317 Q3 | 42 | 26 | 81 | 1457 | 171 | 74 | 2.23 | 56.04 | |
23 | Current Cancer Therapy Reviews | journal | 0.117 Q4 | 17 | 29 | 74 | 2524 | 26 | 65 | 0.41 | 87.03 | |
24 | Current Signal Transduction Therapy | journal | 0.151 Q4 | 22 | 33 | 72 | 1639 | 58 | 65 | 0.67 | 49.67 | |
25 | Current Aging Science | journal | 0.413 Q4 | 42 | 27 | 66 | 1610 | 153 | 63 | 2.18 | 59.63 | |
26 | Current Chemical Biology | journal | 0.142 Q4 | 26 | 26 | 69 | 2002 | 38 | 63 | 0.67 | 77.00 | |
27 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.367 Q4 | 39 | 20 | 64 | 1056 | 132 | 60 | 1.90 | 52.80 | |
28 | Open Biotechnology Journal | journal | 0.374 Q3 | 18 | 20 | 62 | 1315 | 148 | 60 | 2.36 | 65.75 | |
29 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 25 | 64 | 1184 | 43 | 58 | 0.75 | 47.36 | |
30 | Current Pharmacogenomics and Personalized Medicine | journal | 0.139 Q4 | 20 | 13 | 45 | 707 | 23 | 39 | 0.25 | 54.38 | |
31 | Drug Metabolism Letters | journal | 0.357 Q4 | 31 | 24 | 34 | 1151 | 66 | 29 | 1.86 | 47.96 | |
32 | Open Medicinal Chemistry Journal | journal | 0.319 Q4 | 23 | 4 | 30 | 169 | 57 | 27 | 1.50 | 42.25 | |
33 | Open Biomarkers Journal | journal | 0.222 Q4 | 7 | 16 | 23 | 646 | 26 | 23 | 1.41 | 40.38 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®